The Week Ahead: Don't Make This Investing Mistake |
|
November 01, 2015 |
November 2015 Bond Updates
|
The stock market surged and swooned last week on earnings as there was a host of winners and losers. The tech sector had been the big winner the previous week and while LinkedIn (LNKD) surged over 10% last week, Twitter (TWTR) and GoPro (GPRO) recorded double digit losses.
The implications of merger talks between health care giants Pfizer (PFE) and Allergan (AGN) caused new focus on the health care sector which has been lagging on the current rally. Even more important to many investors was the sharp drop in Valeant Pharmaceuticals (VRX) which was rocked by an October 21st report from a noted short seller that VRX could be the next Enron. The stock has lost over 40% since the report was released.
Mutual fund giant Sequoia (SEQUX) has been in the cross hairs as reportedly two of its board members that had questioned the investment in VRX resigned last weekend. This large growth fund has total assets of $7.5 billion and I was surprised to see that it was rated five stars by Morningstar as I have great respect for their research. How can you avoid this mistake?
|
|
View more at: http://www.forbes.com/sites/tomaspray/2015/10/31/the-week-ahead-dont-make-this-investing-mistake/
|